PTGX logo

PTGX EV/EBITDA

Current (TTM)100.35×
PTGX Quarterly EV/EBITDA (-29.71× → 46.35×)
High-resolution chart · PNG

PTGX ev/ebitda history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Protagonist Therapeutics Inc EV/EBITDA — Quarterly
Period endingEV/EBITDA
46.3507×
2,483.7511×
-125.3842×
-106.0453×
-97.769×
-255.4876×
17.2839×
-80.6275×
-60.8155×
7.3441×
42.5712×
-22.7912×
-35.4741×
-31.5742×
-13.1047×
-8.6509×
-6.7421×
-52.7178×
-41.3395×
-22.2373×
-60.4478×
-45.6477×
-37.7537×
-91.4609×
-25.2101×
-8.0068×
-12.5069×
-17.7079×
-8.0737×
-18.4395×
-5.2696×
-15.636×
-8.6722×
-13.7135×
-92.4728×
-50.9919×
-12.0028×
-14.4701×
-30.6086×
-11.7967×
-25.2987×
-5.7735×
-13.1865×
0×
0×
-29.7139×
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.